What conditions are necessary to assess antidepressant efficacy?
Quitkin
F M
FM
New York State Psychiatric Institute, New York 10032, USA.
Klein
D F
DF
D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards*; D003866:Depressive Disorder / Q000188:drug therapy*; D004341:Drug Evaluation / Q000592:standards; D004992:Ethics, Medical; D006801:Humans; D015990:Placebo Effect; D010919:Placebos / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000706:statistics & numerical data
D000928:Antidepressive Agents; D010919:Placebos